How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,709 results for

Antibiotic Food Interactions

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Renal Transplantation

during laparoscopic donor nephrectomy: review of the FDA database. Urology, 2009. 74: 142. 21. Hsi, R.S., et al. Mechanisms of hemostatic failure during laparoscopic nephrectomy: review of Food and Drug Administration database. Urology, 2007. 70: 888. 22. Ponsky, L., et al. The Hem-o-lok clip is safe for laparoscopic nephrectomy: a multi-institutional review. Urology, 2008. 71: 593. 23. Allen, M.B., et al. Donor hemodynamics as a predictor of outcomes after kidney transplantation from donors after (...) the surgical risk in renal transplantation: A case-control study. Nephrol Dial Transplant, 2014. 29: 463. 87. Osman, Y., et al. Necessity of Routine Postoperative Heparinization in Non-Risky Live-Donor Renal Transplantation: Results of a Prospective Randomized Trial. Urology, 2007. 69: 647. 88. Orlando, G., et al. One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: a randomized, controlled clinical trial. Surgery, 2015. 157: 104. 89. Choi, S.U., et al. Clinical

2018 European Association of Urology

182. Exploratory steps for the formulation of Belgian health system targets

-Capitale – Gemeenschappelijke Gemeenschapscommissie van Brussel-Hoofdstad), Rik Thys (De Spiegel vzw), Saskia Van den Bogaert (FOD Volksgezondheid – SPF Santé Publique), Pieter Vandenbulcke (Vlaams Agentschap Zorg en Gezondheid), Elisabeth Van Eycken (BVRO – ABRO, VBS – GBS radiotherapie oncologie). Participation in scientific or experimental research as an initiator, principal investigator or researcher: Karin De Ridder (Belgian Food Consumption Survey 2014, Exposure risk assessments), Stefaan (...) health system targets 5 LIST OF ABBREVIATIONS ABBREVIATION DEFINITION ACE-inhibitors Angiotensin-Converting-Enzyme inhibitor AMCRA Centre of Expertise on Antimicrobial Consumption and Resistance in Animals – Kenniscentrum voor antibioticagebruik en -resistentie bij dieren in België – Centre d'expertise pour l'usage et les résistances aux antibiotiques chez les animaux en Belgique AMI Acute Myocardial Infarction ARS Agences Régionales de Santé BAPCOC Belgian Antibiotic Policy Coordination Committee

2017 Belgian Health Care Knowledge Centre

183. British guideline on the management of asthma

including general practitioners, consultants and specialists in respiratory medicine, nurses and pharmacists. The guideline will also be of interest to people with asthma, their parents and carers; those who interact with people with asthma outside of the NHS, such as teachers; voluntary organisations with an interest in asthma; and those planning the delivery of services in the NHS in England, Wales, Northern Ireland and Scotland. 1.2.3 SUMMARY OF UPDATES TO THE GUIDELINE, BY SECTION 2 Key (...) updates: 7.2.3 Frequency of dosing of inhaled corticosteroids, 7.2.4 Comparison of inhaled corticosteroids 8 Inhaler devices Updated: 8.4 Prescribing devices Minor updates: 8.5 Use and care of spacers| 5 British guideline on the management of asthma 9 Management of acute asthma New: 9.9.5 Critical care (in children) Updated: 9.3.8 Antibiotics, 9.3.12 Critical care settings, 9.3.13 Non-invasive ventilation, 9.7 Acute asthma in children, 9.9.3 Intravenous magnesium sulphate (in children), 9.9.4 Other

2016 SIGN

184. Recommendation for Record-Keeping

/perinatal complications, developmental consid- erations, feeding and dietary practices, timing of first tooth appearance, and tooth brushing initiation and timing as well as toothpaste use. Assessment of developmental milestones (e.g., gross/fine motor skills, language, social interactions) is crucial for early recognition of potential delays and appropriate referral to therapeutic services. 13 As a majority of infants and toddlers of employed mothers receive childcare on a regular basis from persons (...) . In issuing this information, the AAPD is not engaged in rendering legal or other professional advice. If such services are required, competent legal or other profes- sional counsel should be sought. Appendix I—Medical history* Name and nickname Date of birth Gender Race/ethnicity Name, address, and telephone number of all physicians Date of last physical examination Immunization status Summary of health problems Any health conditions that necessitate antibiotics or other medications prior to dental

2017 American Academy of Pediatric Dentistry

185. Policy on the Use of Lasers for Pediatric Dental Patients

by the Food and Drug Administration in 1990. 3 Since then, laser technology has advanced significantly. The use of lasers is contributing to many areas of dentistry including periodontics, pediatrics, endodontics, oral surgery, restorative dentistry and dental hygiene, cosmetic dental whitening, and manage- ment of temporomandibular joint pain to name a few. Laser basics While a detailed description of how lasers work is beyond the scope of this document, it is important to understand the basics of laser (...) operating parameters such as power, frequency, emission mode, thermal relaxation time, and air and water coolant used affect the clinical abilities of a laser. Additionally, the delivery system of laser unit as well as the tissue concentration of the chromophore greatly influence the laser tissue interactions. Various types of lasers have been used in dentistry. Clinical applications of the lasers commonly used in pediatric den- tistry are listed in the Table. Laser safety Laser plume, a mixture

2017 American Academy of Pediatric Dentistry

186. BSR guideline on the management of gout

are three IL-1 inhibitors that have been investigated to some extent for the management of acute gout [ ]. In an RCT, the mAb anti-human IL-1β antibody canakinumab (150 mg by subcutaneous injection) showed good efficacy in reducing pain and swelling when compared with 40 mg intramuscular triamcinolone acetonide [ , ]. Canakinumab is licensed for use in Europe by the European Medicines Agency (EMA) but not in the USA by the Food and Drug Administration (FDA) because of uncertainty about its risk/benefit (...) important concerns relating to drug safety and drug interactions that are seldom adequately discussed [ ]. (iii) In overweight patients, dietary modification to achieve a gradual reduction in body weight and subsequent maintenance should be encouraged. Diet and exercise should be discussed with all patients with gout, and a well-balanced diet low in fat and added sugars, and high in vegetables and fibre should be encouraged: sugar-sweetened soft drinks containing fructose should be avoided; excessive

Full Text available with Trip Pro

2017 British Society for Rheumatology

187. Selected practice recommendations for contraceptive use

Fund (UNFPA) – Sennen Hounton United States Food and Drug Administration (FDA) – Lisa Soule United States National Institutes of Health (NIH) – Alicia Armstrong, Trent MacKay United States Agency for International Development (USAID) – Patricia MacDonald, James Shelton 3External Peer Review Group Abu Faisel (EngenderHealth, Bangladesh), Pio Ivan Gomez (International Planned Parenthood Federation/Western Hemisphere Region and Tenured Professor National University of Columbia, Colombia), Mihai Horga (...) pill) says to take one pill within 72 hours after unprotected intercourse. The United States Food and Drug Administration has in addition declared the following 19 brands of oral contraceptives to be safe and effective for emergency contraception: Ogestrel® (one dose is two white pills), Nordette® (one dose is four light-orange pills), Cryselle®, Levora®, Low-Ogestrel®, Lo/Ovral®, or Quasence® (one dose is four white pills), Jolessa®, Portia®, Seasonale® or Trivora® (one dose is four pink pills

2017 World Health Organisation Guidelines

188. Vitamin D supplements may reduce the chance of developing a chest infection

by viruses, though some infections due to bacteria can require antibiotics. In 2016 the Scientific Advisory Committee on Nutrition (SACN) review on vitamin D and health recommended adults take 10µg vitamin D per day throughout the year based on the benefits for musculoskeletal health. The SACN at the time, found conflicting evidence on whether vitamin D supplements reduce risk of respiratory tract infection or other non-musculoskeletal outcomes and recommended more research into these areas (...) analysed separately, or for other outcomes of interest, like hospital admissions, school or work absence. It’s uncertain whether the findings could lead to a modification to the general population recommendations on vitamin D supplementation, as many following PHE advice will be already taking supplements. Another potential avenue the authors suggest considering for population health is fortification of foods with vitamin D. This is not something that is currently recommended or covered

2019 NIHR Dissemination Centre

189. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting

recommend a formal audiometric evaluation every 5 years regardless of the initial age at diagnosis, initial hearing threshold levels, karyotype and/or presence of a mid-frequency sensorineural hearing loss, to assure early and adequate technical and other rehabilitative measures (⨁⨁◯◯). R 6.2. We recommend aggressive treatment of middle-ear disease and otitis media (OM) with antibiotics and placement of myringotomy tubes as indicated (⨁⨁◯◯). R 6.3. We recommend screening for hypothyroidism at diagnosis

Full Text available with Trip Pro

2016 European Society of Human Reproduction and Embryology

190. Fluoroquinolone Prescribing and Use in Canadian Primary Care Practice

Fluoroquinolone Prescribing and Use in Canadian Primary Care Practice Fluoroquinolone Prescribing and Use in Canadian Primary Care Practice | CADTH.ca CADTH Document Viewer Fluoroquinolone Prescribing and Use in Canadian Primary Care Practice Table of Contents Search this document Fluoroquinolone Prescribing and Use in Canadian Primary Care Practice May 2017 1. Introduction CADTH undertook a study into antibiotic prescribing and use in Canadian primary care practice, with a particular emphasis (...) on fluoroquinolone use. The study investigated current practices and implementation issues for antibiotic therapies from the perspective of family physicians (FPs), nurse practitioners (NPs), and pharmacists. The research findings are based on the results of qualitative research in the form of surveys of primary care practitioners, as well as on a targeted review of the literature on fluoroquinolones use in Canada. CADTH sought to understand and explain experiences and decision-making processes around outpatient

2017 CADTH - Plasma Products

191. Tympanostomy Tubes in Children with Otitis Media

of swimming or head immersion while bathing, canal occlusion methods (e.g. earplugs or headbands), and postexposure prophylaxis using ototopical antibiotics. KQ 5 compares ototopical preparations, and includes products approved by the U.S. Food and Drug Administration (FDA) (i.e., ofloxacin otic 0.3%, ciprofloxacin 0.3% and dexamethasone 0.1%), and other non–FDA-approved agents, such as hydrocortisone, bacitracin, and colistin. Comparators For KQ 1, comparisons of primary interest were watchful waiting (...) antibiotics or watchful waiting. vii Contents Executive Summary ES-1 Introduction 1 Background and Objectives 1 Key Questions 2 Analytic Frameworks 3 Methods 6 Eligibility Criteria 6 Populations 6 Interventions/Exposures 6 Comparators 7 Outcomes 7 Timing 7 Setting 7 Study Design 8 Evidence Identification 8 Data Extraction and Data Management 8 Assessment of Methodological Risk of Bias of Individual Studies 9 Data Synthesis 9 Grading the Strength of Evidence 10 Assessing Applicability 11 Results 12 Key

2017 Effective Health Care Program (AHRQ)

192. The Management of Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum

comorbidity (such as urinary tract infection and inability to tolerate oral antibiotics). RCOG Green-top Guideline No. 69 2 of 27 © Royal College of Obstetricians and Gynaecologists D P P D C P D CWhat therapeutic options are available for NVP and HG? What is the safety and efficacy of pharmacological agents? Antiemetics There are safety and efficacy data for first-line antiemetics such as antihistamines (H1 receptor antagonists) and phenothiazines and they should be prescribed when required for NVP (...) to tolerate food and fluids, effect on quality of life History to exclude other causes: – abdominal pain – urinary symptoms – infection – drug history – chronic Helicobacter pylori infection Examination Temperature Pulse Blood pressure Oxygen saturations Respiratory rate Abdominal examination Weight Signs of dehydration Signs of muscle wasting Other examination as guided by history Investigation Urine dipstick: – quantify ketonuria as 1+ ketones or more MSU Urea and electrolytes

2016 Royal College of Obstetricians and Gynaecologists

193. Diagnosis and treatment of respiratory illness in children and adults.

it in a WARC, and then uploads that WARC to ArchiveTeam servers for eventual injection into the Internet Archive (or other archive sites). To use ArchiveBot, drop by #archivebot on EFNet. To interact with ArchiveBot, you issue commands by typing it into the channel. Note you will need channel operator permissions in order to issue archiving jobs. The dashboard shows the sites being downloaded currently. There is a dashboard running for the archivebot process at . ArchiveBot's source code can be found (...) and Treatment of Respiratory Illness in Children and Adults (see the "Guideline Availability" field). Viral Upper-Respiratory Infections Antibiotics Recommendation : The ICSI work group does not recommend antibiotics for treatment of common cold symptoms in children and adults. Quality of Evidence : Low; Strength of Recommendation : Strong Benefit : Not treating with antibiotics eliminates the possible side effects of antibiotics such as nausea, vomiting, allergic reactions and Clostridium Difficile

2017 National Guideline Clearinghouse (partial archive)

194. Cystic fibrosis: diagnosis and management.

for eventual injection into the Internet Archive (or other archive sites). To use ArchiveBot, drop by #archivebot on EFNet. To interact with ArchiveBot, you issue commands by typing it into the channel. Note you will need channel operator permissions in order to issue archiving jobs. The dashboard shows the sites being downloaded currently. There is a dashboard running for the archivebot process at . ArchiveBot's source code can be found at . TIMESTAMPS Search Sign In Username or Email * Password (...) fibrosis and their family members or carers (as appropriate). Consider telemedicine or home visits for routine monitoring when they are more appropriate than outpatient visits and if the person with cystic fibrosis prefers it. Make arrangements (including providing equipment and expert support) for people to have intravenous antibiotic therapy at home, when this is appropriate. Multidisciplinary Team The specialist cystic fibrosis multidisciplinary team should include at least one of each (depending

2017 National Guideline Clearinghouse (partial archive)

195. Chronic obstructive pulmonary disease.

for eventual injection into the Internet Archive (or other archive sites). To use ArchiveBot, drop by #archivebot on EFNet. To interact with ArchiveBot, you issue commands by typing it into the channel. Note you will need channel operator permissions in order to issue archiving jobs. The dashboard shows the sites being downloaded currently. There is a dashboard running for the archivebot process at . ArchiveBot's source code can be found at . TIMESTAMPS Search Sign In Username or Email * Password (...) to bronchodilators for patients with frequent exacerbations despite bronchodilator therapy [I-A] or with features suggestive of asthma-COPD overlap [II-D] . Supplemental oxygen if resting oxygen saturation ≤88% or arterial partial pressure of oxygen (PaO 2 ) ≤ 55 mm Hg [I-A] . Acute exacerbation medication management includes bronchodilators (beta-2 agonists and anticholinergics) [I-C] , systemic corticosteroid therapy [I-A] , and antibiotics [II-A] based on clinical indications (see Table 9 in the original

2017 National Guideline Clearinghouse (partial archive)

196. Let?s talk about protection: enhancing childhood vaccination uptake public health guidance

). To address this, they need to seek out, or regularly receive from their health authorities, independent and evidence-based information from trustworthy sources. A regular update of vaccine- related information should be a routine part of every provider’s continuing medical education. Associations and academic centres can help by building relevant updates into their course offerings. It is also important to actively interact with agencies responsible for the scientific evaluation of medicines developed (...) or video. f. Observe other staff with patients. g. Practice injections. h. Read Vaccine Information Statements. i. Be mentored by someone who has these skills. j. Role-play with other staff, interactions with parents and patients, including age-appropriate comfort measures. k. Attend a skills training or other courses or training. l. Attend healthcare customer satisfaction or cultural competency training. m. Renew CPR certification. Other: 28 Enhancing childhood vaccination uptake 29 Section 4

2016 European Centre for Disease Prevention and Control - Public Health Guidance

197. Communication strategies for the prevention of HIV, STI and hepatitis among MSM in Europe

, STI and hepatitis among MSM in Europe TECHNICAL DOCUMENT 6 Trust can be built by adopting an affirmative stance toward MSM’s right to a fulfilling sexual life, rather than defining MSM or their behaviour as a problem. Trust needs time to develop and requires many interactions over time. Communicating challenging, controversial messages at the beginning of a trust-building period is probably premature; messages will be more effective once a certain level of trust has been established. 3.3 Promote (...) interactions such as counselling or outreach. To understand this information requires a higher level of health literacy, including an understanding of human physiology, the life cycles of microorganisms, and knowledge of different forms of sexual expression. Once the audience has understood the science that underpins prevention messages, they are more likely to use it as the basis for their long-term choices. Unintended effects of fear-based communication This approach refers to using shocking

2016 European Centre for Disease Prevention and Control - Technical Guidance

198. Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU/EEA

, University of Oxford, United Kingdom; Taneli Puumalainen, National Institute for Health and Welfare, Finland; Lukas Richter, Austrian Agency for Health and Food Safety, Austria; George A. Syrogiannopoulos, University of Thessaly, Greece; Maria Paula Valente, Directorate General of Health, Portugal; Ole Wichmann, Robert Koch Institute, Germany Suggested citation: European Centre for Disease Prevention and Control. Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU/EEA (...) /EEA was first coordinated by the European Union Invasive Bacterial Infections Surveillance Network (EU-IBIS) at Public Health England from 1999–2007 and subsequently transferred to ECDC. Since then, the annual data collection from 30 Member States has been carried out through the European Surveillance System (TESSy) platform at ECDC [20]. Case-based data on IMD are received from 30 Member States. IMD surveillance data up to 2015 are available online from the interactive ECDC Surveillance Atlas

2017 European Centre for Disease Prevention and Control - Expert Opinion

199. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

, the rate in a sibling is 2.1%, a relative risk of ≈10-fold compared with the Japanese population in general; approximately half of the second cases develop within 10 days of the first case. The risk of concordance in identical twins is ≈13%. Higher rates of KD in siblings of index cases and twins are consistent with a genetic predisposition that interacts with exposure to the pathogenic agent or agents in the environment. , , , The reported occurrence of KD in children of parents who themselves had (...) be considered if adenovirus is detected in a patient with nonexudative pharyngitis. Other diagnostic features of KD not commonly observed in adenovirus infection include erythema and swelling of the hands and feet, strawberry tongue, and a desquamating groin rash. In children with some clinical features of KD and a positive rapid test or culture for group A streptococcus who do not improve after 24 to 48 hours of effective antibiotic therapy (streptococcal carriers), the diagnosis of KD should be again

2017 American Heart Association

200. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

aortic root size for AVR (may preclude valve-in-valve procedure in future). AF indicates atrial fibrillation; AVR, aortic valve replacement; INR, International Normalized Ratio; and VKA, vitamin K antagonist. Downloaded from http://ahajournals.org by on March 27, 20192017 AHA/ACC VHD Focused Update Circulation. 2017;135:e1159–e1195. DOI: 10.1161/CIR.0000000000000503 June 20/27, 2017 e1173 CLINICAL STATEMENTS AND GUIDELINES tion vary with the specific drug, absorption, various foods, alcohol, other (...) : impact of the 2007 Ameri- can Heart Association Antibiotic Prophylaxis Guidelines? Am Heart J? 2012;163:894–9? 20? Pant S, Patel NJ, Deshmukh A, et al? Trends in infective endocar- ditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011? J Am Coll Cardiol? 2015;65:2070–6? 21? Thornhill MH, Dayer MJ, Forde JM, et al? Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study? BMJ

2017 American Heart Association

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>